Volume 1, Problème 9 (2011)
Prospective Thérapeutique
Chemoprevention of prostate cancer: is there evidence from clinical trials?
Marcelo Langer Wroclawski, Cynthia Kuk, Antonio Finelli, Neil E Fleshner, Alexandre R Zlotta
Prospective Thérapeutique
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Article de révision
Biologic monotherapy for the treatment of rheumatoid arthritis
Andrew Taylor, Graeme Jones
Article de révision
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Article de révision
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
Article de révision
Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress
Monica Millan, Antoni Davalos
Résultats des essais cliniques
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
Procédure
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Résultats des essais cliniques
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
